New research showed that tirzepatide, the compound in Zepbound, improved symptoms of obstructive sleep apnea.

Eli Lilly (LLY) files for the approval of tirzepatide to treat obstructive sleep apnea in adults with obesity in the United States. If approved, sales...

Researchers at University of California San Diego School of Medicine and international collaborators have led a worldwide, advanced study...

In recent research led by the University of California San Diego School of Medicine, scientists have found a new potential treatment for obstructive...

The Subject Expert Committee (SEC), which advises the national drug regulator on drugs and trials approval matters, has recommended grant of...

Sleep apnea is a common but serious disorder where breathing repeatedly stops and starts during sleep. This condition can lead to daily fatigue,...

Research raises possibility that tirzepatide could become first pharmaceutical treatment for the sleeping disorder

Cleveland Clinic study reveals that weight loss surgery significantly reduces the risk of heart complications by 42% and the risk of death by 37% in...

Pharmaceutical company Eli Lilly is taking legal action against wellness centers, medical spas and other parties passing off fake medicine as Lilly...

On June 12, 2024, the Food and Drug Administration granted traditional approval to selpercatinib (Retevmo, Eli Lilly and Company) for adult and...